GENERIC NAME OF THE MEDICINAL PRODUCT:

Ciprofloxacin Intravenous Infusion BP (0.2%w/v or 200mg/100ml)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Ciprofloxacin Intravenous Infusion BP (0.2% W/V or 200mg/100ml)
Composition:
Each 100ml contains:
Ciprofloxacin HCL BP
Eq. to Ciprofloxacin……………………………0.2g
Sodium chloride BP…………………………… 0.9%w/v
Water for Injection BP…………………………. q.s.
mOsmol/L.: 314
mmol/L: Na154, CI154

THERAPEUTIC INDICATIONS:

Ciprofloxacin injection is used to treat certain infections caused by bacteria such as pneumonia; and infections of the skin, bone, joint, abdomen (stomach area), urinary tract, and prostate (male reproductive gland).

DIRECTION OF USE:

To be used with Non-pyrogenic I.V. administration set with aseptic technique.
For I.V. use only.

CAUTION & WARNING:

CAUTION: Even Invisible damage to bottle during transit, Storage or handling may result in contamination. Do not use if contamination is found leaking on squeezing, content not clear or contains visible solid particle.
WARNING: TO BE SOLD BY THE RETAILERS ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.

STORAGE & DOSAGE:

Storage: Store below 25°C.
Protect from light.
Do not freeze.
STERILE, NON-PYROGENIC, SINGLE DOSE CONTAINER.
Keep medicine out of reach of children.
FOR HUMAN USE ONLY
Read enclosed leaflet before use
Dosage: As directed by the Physician.

Ciprofloxacin Intravenous Infusion BP 2mg/ml (ciprotaj) Technical Specification:

Product Name:Ciprofloxacin Intravenous Infusion BP 2mg/ml
Brand Name:ciprotaj
Strength:(0.2%w/v or 200mg/100ml or 2mg/ml)
Dosage Form:I.V. Infusion Bottle (LVP)
Packing:100mL, 200mL IV Bottle
Route of Administration:For I.V. use only
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Anti-bacterial & antibiotics (fluoroquinolone antibiotics)
Indication: Ciprofloxacin injection is used to treat certain infections caused by bacteria such as pneumonia; and infections of the skin, bone, joint, abdomen (stomach area), urinary tract, and prostate (male reproductive gland).
Storage:Store below 25°C. Protect from light. Do not freeze.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Ciprofloxacin Intravenous Infusion BP (0.2%w/v or 200mg/100ml)

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Ciprofloxacin Intravenous Infusion BP (0.2% W/V or 200mg/100ml)
    Composition:
    Each100ml contains:
    Ciprofloxacin HCL BP
    Eq. to Ciprofloxacin……………………………0.2g
    Sodium chloride BP…………………………… 0.9%w/v
    Water for Injection BP…………………………. q.s.
    mOsmol/L.: 314
    mmol/L: Na154, CI154

THERAPEUTIC INDICATIONS:

Ciprofloxacin injection is used to treat certain infections caused by bacteria such as pneumonia; and infections of the skin, bone, joint, abdomen (stomach area), urinary tract, and prostate (male reproductive gland).

 DIRECTION OF USE:

To be used with Non-pyrogenic I.V. administration set with aseptic technique.

For I.V. use only.

 CAUTION & WARNING:

CAUTION: Even Invisible damage to bottle during transit, Storage or handling may result in contamination. Do not use if contamination is found leaking on squeezing, content not clear or contains visible solid particle.

WARNING: TO BE SOLD BY THE RETAILERS ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.

STORAGE & DOSAGE:

Storage: Store below 25°C. Protect from light. Do not freeze.
STERILE, NON-PYROGENIC, SINGLE DOSE CONTAINER.

Keep medicine out of reach of children.
FOR HUMAN USE ONLY

Read enclosed leaflet before use

Dosage: As directed by the Physician.